Study title: Jenkin-R-D, Anderson-J-R, Chilcote-R-R, Coccia-P, Exelby-P, Kersey-J, Kjeldsberg-C-R, Kushner-J, Meadows-A-T, Siegel-S, et al. The treatment of diffuse undifferentiated non-Hodgkin's lymphoma in children: the Childrens Cancer Study Group experience. IARC scientific publications, {IARC-Sci-Publ}, 1985, no. 60, p. 399-404, ISSN: 0300-5038.Jenkin-R-D, Anderson-J-R, Chilcote-R-R, Coccia-P, Exelby-P, Kersey-J, Kjeldsberg-C-R, Kushner-J, Meadows-A-T, Siegel-S, et al. The treatment of diffuse undifferentiated non-Hodgkin's lymphoma in children: the Childrens Cancer Study Group experience. IARC scientific publications, {IARC-Sci-Publ}, 1985, no. 60, p. 399-404, ISSN: 0300-5038.
| Type of medicine: Medicines containing chemical active substances | |||||
| Therapeutic area: Neoplasms [C04] | |||||
| Brands: Please see report | |||||
| MAH holders: Please see report | |||||
| Assessment: | |||||
| Active substance: PROCARBAZINE | |||||
| ATC code: | |||||
| Document link: | |||||
| Document date: | |||||
| Study number: | |||||
| EudraCT number: | |||||
| Scope of study: Clinical | |||||
| Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
| - | - | - | Y | - | |